| Primary |
| Hypertonic Bladder |
32.6% |
| Urinary Incontinence |
10.7% |
| Pollakiuria |
9.3% |
| Hypertension |
8.3% |
| Incontinence |
5.5% |
| Diabetes Mellitus |
4.2% |
| Micturition Urgency |
4.2% |
| Bladder Disorder |
4.1% |
| Ill-defined Disorder |
2.7% |
| Blood Cholesterol Increased |
2.5% |
| Depression |
2.5% |
| Thyroid Disorder |
2.2% |
| Pain |
2.0% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Cardiac Disorder |
1.4% |
| Arthritis |
1.3% |
| Nocturia |
1.3% |
| Anxiety |
1.3% |
| Urge Incontinence |
1.3% |
| Sleep Disorder |
1.1% |
|
| Drug Ineffective |
24.9% |
| Death |
9.9% |
| Dry Mouth |
9.6% |
| Urinary Incontinence |
7.3% |
| Pollakiuria |
6.0% |
| Urinary Retention |
5.7% |
| Vision Blurred |
4.3% |
| Nocturia |
4.2% |
| Constipation |
4.0% |
| Weight Increased |
3.6% |
| Weight Decreased |
3.5% |
| Urinary Tract Infection |
2.2% |
| Dizziness |
2.0% |
| Headache |
2.0% |
| Hypertension |
2.0% |
| Pain |
2.0% |
| Rash |
2.0% |
| Dysuria |
1.8% |
| Drug Effect Decreased |
1.6% |
| Insomnia |
1.6% |
|
| Secondary |
| Hypertonic Bladder |
17.9% |
| Hypertension |
10.3% |
| Pollakiuria |
8.3% |
| Urinary Incontinence |
7.6% |
| Blood Cholesterol Increased |
6.5% |
| Bladder Disorder |
6.5% |
| Incontinence |
4.9% |
| Depression |
4.6% |
| Diabetes Mellitus |
4.5% |
| Product Used For Unknown Indication |
4.5% |
| Micturition Urgency |
4.3% |
| Pain |
3.5% |
| Drug Use For Unknown Indication |
3.2% |
| Arthritis |
2.6% |
| Anxiety |
2.2% |
| Cystitis Interstitial |
1.8% |
| Nocturia |
1.8% |
| Thyroid Disorder |
1.8% |
| Bipolar Disorder |
1.6% |
| Fibromyalgia |
1.6% |
|
| Drug Ineffective |
20.1% |
| Urinary Incontinence |
9.9% |
| Weight Increased |
7.4% |
| Dry Mouth |
7.0% |
| Death |
6.7% |
| Vision Blurred |
6.3% |
| Pollakiuria |
5.6% |
| Weight Decreased |
5.6% |
| Urinary Retention |
4.9% |
| Dizziness |
3.9% |
| Fall |
2.8% |
| Surgery |
2.5% |
| Swelling Face |
2.5% |
| Blood Pressure Increased |
2.1% |
| Drug Level Increased |
2.1% |
| Fatigue |
2.1% |
| Gait Disturbance |
2.1% |
| Muscle Spasms |
2.1% |
| Off Label Use |
2.1% |
| Oropharyngeal Blistering |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
15.0% |
| Multiple Sclerosis |
8.4% |
| Depression |
7.1% |
| Hypertension |
6.2% |
| Pain |
5.5% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Anxiety |
3.4% |
| Rheumatoid Arthritis |
3.2% |
| Blood Cholesterol Increased |
2.9% |
| Urinary Incontinence |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Osteoporosis |
2.2% |
| Sleep Disorder |
2.1% |
| Bladder Disorder |
2.0% |
| Diabetes Mellitus |
1.8% |
| Hypertonic Bladder |
1.7% |
| Vitamin Supplementation |
1.7% |
| Arthritis |
1.7% |
| Back Pain |
1.7% |
|
| Vomiting |
12.0% |
| Urinary Tract Infection |
10.4% |
| Weight Decreased |
9.1% |
| Weight Increased |
9.1% |
| Pain |
6.6% |
| Drug Ineffective |
5.3% |
| Nausea |
4.6% |
| Somnolence |
4.6% |
| Death |
4.0% |
| Pneumonia |
3.6% |
| Rash |
3.6% |
| Vision Blurred |
3.5% |
| Pulmonary Embolism |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Dyspnoea |
3.0% |
| Tremor |
3.0% |
| Oedema Peripheral |
2.8% |
| Progressive Multifocal Leukoencephalopathy |
2.8% |
| Road Traffic Accident |
2.8% |
|
| Interacting |
| Systemic Lupus Erythematosus |
12.6% |
| Blood Pressure |
11.2% |
| Asthma |
8.4% |
| Pollakiuria |
7.7% |
| Pain |
7.0% |
| Urinary Incontinence |
7.0% |
| Headache |
6.3% |
| Hypertonic Bladder |
5.6% |
| Hormone Replacement Therapy |
4.2% |
| Muscle Spasms |
4.2% |
| Sleep Disorder |
4.2% |
| Thyroid Disorder |
4.2% |
| Smoking Cessation Therapy |
2.8% |
| Anxiety |
2.1% |
| Bone Disorder |
2.1% |
| Convulsion |
2.1% |
| Gastritis |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hypersensitivity |
2.1% |
| Hypertension |
2.1% |
|
| Vomiting |
24.0% |
| Urinary Retention |
16.0% |
| Tremor |
12.0% |
| Hallucination |
8.0% |
| Syringomyelia |
8.0% |
| Drug Interaction |
4.0% |
| Erectile Dysfunction |
4.0% |
| Fall |
4.0% |
| Joint Swelling |
4.0% |
| Nervousness |
4.0% |
| Osteonecrosis |
4.0% |
| Pollakiuria |
4.0% |
| Urine Odour Abnormal |
4.0% |
|
